1. Home
  2. DRD vs ZLAB Comparison

DRD vs ZLAB Comparison

Compare DRD & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$21.10

Market Cap

2.5B

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$20.49

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
ZLAB
Founded
1895
2013
Country
South Africa
China
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DRD
ZLAB
Price
$21.10
$20.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$32.63
$49.60
AVG Volume (30 Days)
367.0K
874.3K
Earning Date
08-19-2026
05-07-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$39.23
$9.75
Revenue Next Year
$30.12
$26.03
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
15.33
52 Week Low
$13.25
$15.96
52 Week High
$39.37
$41.20

Technical Indicators

Market Signals
Indicator
DRD
ZLAB
Relative Strength Index (RSI) 39.48 68.60
Support Level $20.13 $16.84
Resistance Level $32.74 $21.33
Average True Range (ATR) 0.82 0.75
MACD 0.10 0.29
Stochastic Oscillator 40.58 93.73

Price Performance

Historical Comparison
DRD
ZLAB

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: